Structural comparison of μ-opioid receptor selective peptides confirmed four parameters of bioactivity
A Borics, G Tóth - Journal of Molecular Graphics and Modelling, 2010 - Elsevier
Structural determinants of binding to the μ-opioid receptor, an important target in analgesia,
attract great scientific attention. Many natural and synthetic peptides and peptidomimetics …
attract great scientific attention. Many natural and synthetic peptides and peptidomimetics …
Molecular modeling of µ opioid receptor ligands with various functional properties: PZM21, SR-17018, morphine, and fentanyl—simulated interaction patterns …
S Podlewska, R Bugno, L Kudla, AJ Bojarski… - Molecules, 2020 - mdpi.com
Molecular modeling approaches are an indispensable part of the drug design process. They
not only support the process of searching for new ligands of a given receptor, but they also …
not only support the process of searching for new ligands of a given receptor, but they also …
[图书][B] Development of a model for the mu opioid receptor pharmacophore
JCK Ho - 1997 - search.proquest.com
A series of conformationally restricted analogs of the cyclic $\mu $ opioid receptor selective
tetrapeptide Tyr-c (D-Cys-Phe-D-Pen) NH $\sb2 $(S-Et-S)(JOM-6) were prepared in order to …
tetrapeptide Tyr-c (D-Cys-Phe-D-Pen) NH $\sb2 $(S-Et-S)(JOM-6) were prepared in order to …
The μ opioid receptor and ligands acting at the μ opioid receptor, as therapeutics and potential therapeutics
Although the μ opioid receptor (MOR) was pharmacologically and biochemically identified in
binding studies forty years ago, its structure, function, and true complexity only have …
binding studies forty years ago, its structure, function, and true complexity only have …
Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models
C Wang, IJ McFadyen, JR Traynor… - Bioorganic & medicinal …, 1998 - Elsevier
A pair of diastereomeric peptidomimetics based upon opioid receptor-binding
pharmacophore models derived for a series of opioid tetrapeptides was synthesized. Both …
pharmacophore models derived for a series of opioid tetrapeptides was synthesized. Both …
[PDF][PDF] Exploring the interactions of enkephalin and dalargin analogues with the mu-opioid receptor
The μ-opioid receptor (MOR) is an important target in the search for novel analgesics. The
recently published crystal structure of MOR gives the possibility of in silico investigations …
recently published crystal structure of MOR gives the possibility of in silico investigations …
Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: A comparative study
I Bera, A Laskar, N Ghoshal - Journal of molecular modeling, 2011 - Springer
Opioid receptors are the principal targets for opioids, which have been used as analgesics
for centuries. Opioid receptors belong to the rhodopsin family of G-protein coupled receptors …
for centuries. Opioid receptors belong to the rhodopsin family of G-protein coupled receptors …
Computer-Aided Receptor Modelling of Human Opioid Receptors: (Mu, Kappa & Delta)
B Habibi-Nezhad, M Hanifian… - Molecular modeling annual, 1996 - Springer
Opioid receptors (OPRs) are important agents in the centeral nervous system (CNS)
function. These receptors belong to “G-Protein Coupled Receptors (GPCRs)” which have …
function. These receptors belong to “G-Protein Coupled Receptors (GPCRs)” which have …
Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation
X Jiang, S Li, H Zhang, LL Wang - Computational Biology and Chemistry, 2021 - Elsevier
Opioids are well known for their potent analgesic efficacy and severe side effects. Studies
have shown that analgesic effects are mediated by the downstream G-protein-dependent …
have shown that analgesic effects are mediated by the downstream G-protein-dependent …
Ligand recognition in μ opioid receptor: experimentally based modeling of μ opioid receptor binding sites and their testing by ligand docking
T Sagara, H Egashira, M Okamura, I Fujii… - Bioorganic & medicinal …, 1996 - Elsevier
For three-dimensional understanding of the mechanisms that control potency and selectivity
of the ligand binding at the atomic level, we have analysed opioid receptor-ligand interaction …
of the ligand binding at the atomic level, we have analysed opioid receptor-ligand interaction …